The government spends three times as much on cancer medication as ten years ago

Between 2014 and 2023, the expenditure of the RIZIV (the National Service for Sickness and Invalidity Insurance) for medicines is directly linked to cancer and immunotherapies. More than 40 percent of the total medication budget now goes to the fight against cancer and innovative treatments. Thus De Tijd and L’Echo report Friday.

ttn-3